
Metart 25mg/6.25mg Tablet ER
Marketer
Precise Lifescience
Salt Composition
Metoprolol Succinate (25mg) + Chlorthalidone (6.25mg)
Overview Metart 25mg/6.25mg Tablet ER
Hypertension (high blood pressure) is managed with Metart 25mg/6.25mg Extended-Release tablets. This medication is prescribed when a single antihypertensive agent proves insufficient. It significantly lowers the risk of future strokes and heart attacks, and early administration enhances survival rates following a cardiac event. Metart 25mg/6.25mg ER should be taken once daily, preferably in the morning, with or without food, to minimize nighttime urination. Continue treatment as directed by your physician; discontinuation, even with symptom improvement, can worsen your condition. Lifestyle modifications, such as regular physical activity, weight management, and a balanced diet, further support blood pressure control. Closely follow your doctor's instructions. Common side effects include nausea, constipation, diarrhea, and fatigue. Report persistent, worsening, or bothersome side effects immediately. Increased fluid intake may alleviate muscle weakness, dry mouth, and thirst. Initial dizziness or headaches due to blood pressure reduction usually subside. Prior to commencing treatment, inform your doctor of any liver or kidney issues, pregnancy, or breastfeeding. Disclose all other medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, kidney function, blood sugar, and electrolyte levels (potassium, magnesium) is crucial for optimal therapeutic efficacy.
Primary Ingredients of Metart 25mg/6.25mg Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Metart 25mg/6.25mg Tablet ER
Elevated arterial blood pressure
Major Benefits of Metart 25mg/6.25mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metart 25mg/6.25mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Metart 25mg/6.25mg Tablet ER:
- Nausea
- Constipation
- Diarrhea
- Fatigue
- Headache
- Dizziness
- Slow heart rate
- Increased blood uric acid
- Decreased potassium level in blood
- Glucose intolerance
- Altered blood lipid level
- Cold extremities
- Decreased magnesium level in blood
- Increased calcium level in blood
How to use Metart 25mg/6.25mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metart 25mg/6.25mg Extended-Release Tablets may be consumed with or without food, though consistent daily timing is recommended.
How Metart 25mg/6.25mg Tablet ER works:
Metart 25mg/6.25mg Extended-Release tablets combine metoprolol succinate and chlorthalidone to control hypertension. Metoprolol succinate, a beta-adrenergic blocking agent, acts on the heart to decrease heart rate and enhance its pumping efficiency. Chlorthalidone, a diuretic, reduces blood pressure by eliminating excess fluid and electrolytes, while concurrently promoting vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metart 25mg/6.25mg Extended-Release Tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metart 25mg/6.25mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metart 25mg/6.25mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Metart 25mg/6.25mg Extended-Release Tablets may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these side effects.
KidneyCAUTION
Exercise caution when administering Metart 25mg/6.25mg Extended-Release tablets to individuals with severe renal impairment; dosage modification may be necessary. Consult a physician before use. This medication is contraindicated in patients with severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when taking Metart 25mg/6.25mg Extended-Release tablets. Dosage modification may be necessary. Physician consultation is advised. Metart 25mg/6.25mg Extended-Release tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Metart 25mg/6.25mg Tablet ER :
Should you forget a Metart 25mg/6.25mg Extended-Release Tablet, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metart 25mg/6.25mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |
